STRATEC to present at two upcoming Capital Market Conferences

STRATEC to present at two upcoming Capital Market Conferences

Birkenfeld, December 16, 2011

STRATEC Biomedical AG (Frankfurt: SBS; Prime Standard, TecDAX) today announced that the company will present at two international Capital Market Conferences in January 2012:

30^th Annual J.P. Morgan Healthcare Conference
Date: January 9, 2012
Venue: San Francisco, CA, USA

CA Cheuvreux - 11^th German Corporate Conference
Date: January 17, 2012
Venue: Frankfurt/Main, Germany

Copies of the company presentation and links to the webcast, if available, will be provided at www.stratec.com > Investor Relations > Financial Calendar.

About STRATEC
STRATEC Biomedical Systems AG (www.stratec.com) designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. These partners market such systems, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world.

The company develops its products on the basis of its own patented technologies. Shares in the company (ISIN: DE0007289001) are traded in the Prime Standard segment of the Frankfurt Stock Exchange and are listed in the TecDAX select index of the German Stock Exchange.

The STRATEC Group consists of the publicly listed parent company STRATEC Systems AG and of subsidiaries and second-tier subsidiaries in Germany, the USA, the UK, Switzerland and Romania.

Further information can be obtained from:
STRATEC Biomedical AG
André Loy, Investor Relations
Gewerbestr. 37, 75217 Birkenfeld
Germany
Tel: +49 7082 7916-190
Fax: +49 7082 7916-999
ir@stratec.com
www.stratec.com